How are CDK 4/6 Inhibitors changing the way breast cancer is treated?

How are CDK 4/6 Inhibitors changing the way breast cancer is treated?

User Photo
obr

3 years
490 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Neelima Denduluri, MD of Virginia Cancer Specialists discusses how CDK 4/6 inhibitors are changing the treatment of breast cancer at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Up Next Autoplay